|
🐜
|
Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis
25 auth.
A. Hiraoka,
K. Michitaka,
D. Kiguchi,
Hirofumi Izumoto,
Hidetaro Ueki,
Miho Kaneto,
Shogo Kitahata,
Toshihiko Aibiki,
Tomonari Okudaira,
Hideomi Tomida,
Yuji Miyamoto,
H. Yamago,
Yoshifumi Suga,
R. Iwasaki,
Kenichiro Mori,
...
H. Miyata,
Eiji Tsubouchi,
M. Kishida,
T. Ninomiya,
Shigeru Kohgami,
M. Hirooka,
Yoshio Tokumoto,
M. Abe,
B. Matsuura,
Y. Hiasa
|
6 |
2017 |
6
🐜
|
|
🐜
|
Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib
23 auth.
A. Hiraoka,
M. Hirooka,
Y. Koizumi,
Hirofumi Izumoto,
Hidetaro Ueki,
Miho Kaneto,
Shogo Kitahata,
Toshihiko Aibiki,
Hideomi Tomida,
Yuji Miyamoto,
...
H. Yamago,
Yoshifumi Suga,
R. Iwasaki,
Kenichiro Mori,
H. Miyata,
Eiji Tsubouchi,
M. Kishida,
T. Ninomiya,
M. Abe,
B. Matsuura,
H. Kawasaki,
Y. Hiasa,
K. Michitaka
|
6 |
2017 |
6
🐜
|
|
🐜
|
Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection
15 auth.
Toshiyuki Yoshio,
Hideomi Tomida,
R. Iwasaki,
Yusuke Horiuchi,
Masami Omae,
Akiyoshi Ishiyama,
T. Hirasawa,
Yorimasa Yamamoto,
T. Tsuchida,
J. Fujisaki,
...
Takuya Yamada,
E. Mita,
T. Ninomiya,
K. Michitaka,
M. Igarashi
|
5 |
2017 |
5
🐜
|
|
🐜
|
Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma
23 auth.
A. Hiraoka,
Y. Otsuka,
H. Kawasaki,
Hirofumi Izumoto,
Hidetaro Ueki,
Shogo Kitahata,
Toshihiko Aibiki,
Tomonari Okudaira,
H. Yamago,
Yuji Miyamoto,
...
R. Iwasaki,
Hideomi Tomida,
Kenichiro Mori,
H. Miyata,
Eiji Tsubouchi,
M. Kishida,
M. Hirooka,
M. Abe,
B. Matsuura,
T. Ninomiya,
I. Mori,
Y. Hiasa,
K. Michitaka
|
4 |
2018 |
4
🐜
|
|
🐜
|
Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases
24 auth.
Hirofumi Izumoto,
A. Hiraoka,
Yoshihiro Ishimaru,
T. Murakami,
Shogo Kitahata,
Hidetaro Ueki,
Toshihiko Aibiki,
Tomonari Okudaira,
Yuji Miyamoto,
H. Yamago,
...
R. Iwasaki,
Hideomi Tomida,
Kenichiro Mori,
M. Kishida,
Eiji Tsubouchi,
H. Miyata,
T. Ninomiya,
H. Kawasaki,
M. Hirooka,
B. Matsuura,
M. Abe,
Y. Hiasa,
K. Michitaka,
M. Kudo
|
4 |
2017 |
4
🐜
|
|
🐜
|
Proposed a simple score for recommendation of scheduled ultrasonography surveillance for hepatocellular carcinoma after Direct Acting Antivirals: multicenter analysis
25 auth.
A. Hiraoka,
T. Kumada,
C. Ogawa,
K. Kariyama,
M. Morita,
K. Nouso,
H. Toyoda,
T. Tada,
Marie Ochi,
Taisei Murakami,
Hirofumi Izumoto,
Hidetaro Ueki,
Shogo Kitahata,
Toshihiko Aibiki,
Tomonari Okudaira,
...
H. Yamago,
R. Iwasaki,
Hideomi Tomida,
Yuji Miyamoto,
Kenichiro Mori,
H. Miyata,
Eiji Tsubouchi,
M. Kishida,
T. Ninomiya,
K. Michitaka
|
4 |
2018 |
4
🐜
|
|
🐜
|
Easy surveillance of muscle volume decline in chronic liver disease patients using finger‐circle (yubi‐wakka) test
20 auth.
A. Hiraoka,
Hirofumi Izumoto,
Hidetaro Ueki,
Takeaki Yoshino,
Toshihiko Aibiki,
Tomonari Okudaira,
H. Yamago,
Yoshifumi Suga,
R. Iwasaki,
Hideomi Tomida,
...
Kenichiro Mori,
H. Miyata,
Eiji Tsubouchi,
M. Kishida,
T. Ninomiya,
M. Hirooka,
M. Abe,
B. Matsuura,
Y. Hiasa,
K. Michitaka
|
4 |
2019 |
4
🐜
|
|
🐜
|
Muscle volume loss a prognostic factor for death in liver cirrhosis patients and special relationship to portal hypertension
21 auth.
A. Hiraoka,
Shogo Kitahata,
Hirofumi Izumoto,
Hidetaro Ueki,
Toshihiko Aibiki,
Tomonari Okudaira,
Yuji Miyamoto,
H. Yamago,
R. Iwasaki,
Hideomi Tomida,
...
Kenichiro Mori,
M. Kishida,
Eiji Tsubouchi,
H. Miyata,
T. Ninomiya,
M. Hirooka,
Yoshio Tokumoto,
M. Abe,
B. Matsuura,
Y. Hiasa,
K. Michitaka
|
4 |
2018 |
4
🐜
|
